1. Home
  3. GABA Powder

LiftMode

GABA Powder

$7.68
$12.68 $7.68
-$5.00
Unit Size: 5g
SKU: SF-47K0-3MG1

GABA (Gamma-aminobutyric acid) is a well-known hormone that is produced by the brain to help reduce signals from the central nervous system (CNS) and binds to receptors in the GABAergic system. It has a chemical formula of C4H9NO2 and a molecular mass of 103.12 g/mol.

Description

GABA Benefits and Uses

Gamma-aminobutyric acid is a naturally produced hormone and is the principal inhibitory neurotransmitter in the mammalian central nervous system (CNS) and is synthesized naturally from glutamate.

It does not have a high capacity to cross the blood-brain barrier. However, anecdotal reports suggest that its effects may be similar to other calming supplements.

Scientific Consensus

Supplementing with this product is likely to be safe, even at larger serving sizes, but there is a need for further research into potential adverse effects, especially for pregnant or breastfeeding women. GABA has the potential to interact with some medications, and caution should be used.

It is not yet clear that a significant portion of GABA reaches the brain when taken orally. The significance of GABA’s benefits will only be apparent after further scientific evidence becomes available.

DO NOT EXCEED THE RECOMMENDED SERVING SIZE. Use with caution. Do not use if pregnant or breastfeeding.

Instructions & Ingredients

Serving size is 1000 mg. As a dietary supplement, take 1-2 servings up to 3 times per day. Please start with the lowest suggested single serving quantity to assess response.

Supplement Facts
Serving size: 1000mg Servings per container: 5
Amount per serving % DV
γ-Aminobutyric Acid (GABA) 1000 mg ‡
‡ Daily Value not established.

Where To Buy

LiftMode offers a variety of unit sizes of HPLC-tested GABA Powder, including a 5g unit and a 400g unit. Our GABA Powder is of the highest quality.

Disclaimer & Other Info

Store securely in a dry cool location away from direct sunlight. Keep out of reach of children and pets. Do not take this or any other supplement, and instead consult doctor about use, if you are under the age of 18, pregnant or breastfeeding, taking prescription or OTC / nonprescription drugs, or if you have any known or suspected medical conditions. Do not use if product safety seal was damaged or missing upon receipt.

The statements on this page have not been evaluated by the FDA. The products on this page are not intended to diagnose, treat, cure, or prevent any disease.
$7.68
$12.68 $7.68
  • Filler Free Icon

    Free from additives and fillers

  • Gluten Free Icon

    Gluten Free

  • Lab Tested Icon

    HPLC Lab tested

  • GMO Free Icon

    Non-GMO

  • Science Backed Icon

    Science backed

  • Vegan Icon

    Vegan

Scientifically Tailored Ingredients

  • GABA
GABA
GABA

GABA

GABA is a naturally occurring amino acid which is the chief inhibitory neurotransmitter in the mammalian central nervous system. GABA promotes a calm mood and is used as an ingredient in dietary supplement products. - Calming - Promotes a Healthy Nervous System - Supports Healthy Sleep

References

Boonstra, E., de Kleijn, R., Colzato, L. S., Alkemade, A., Forstmann, B. U., & Nieuwenhuis, S. (2015). Neurotransmitters as food supplements: the effects of GABA on brain and behavior. Frontiers in psychology, 6, 1520. doi:10.3389/fpsyg.2015.01520.

Byun, J. I., Shin, Y. Y., Chung, S. E., & Shin, W. C. (2018). Safety and Efficacy of Gamma-Aminobutyric Acid from Fermented Rice Germ in Patients with Insomnia Symptoms: A Randomized, Double-Blind Trial. Journal of clinical neurology (Seoul, Korea), 14(3), 291–295. doi:10.3988/jcn.2018.14.3.291.

Gamma-aminobutyric Acid: Compound Summary (2019). PubChem. U.S. National Library of Medicine. [online]. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/gamma-Aminobutyric-acid.

Gottesmann, C. (2002). GABA mechanisms and sleep. Neuroscience, 111(2), 231–239. doi:10.1016/s0306-4522(02)00034-9.

Wu, C., & Sun, D. (2015). GABA receptors in brain development, function, and injury. Metabolic brain disease, 30(2), 367–379. doi:10.1007/s11011-014-9560-1